Biora Therapeutics (NASDAQ:BIOR) short interest has risen to more than 243%. More than double the company’s float...
Business News
David Inggs is Global Head of Operations at Citadel and is responsible for all products across asset...
The U.S. Federal Reserve is probing whether Goldman Sachs Group Inc’s consumer business had appropriate safeguards in place...
[Bloomberg] Billionaire hedge fund manager Ken Griffin sued the USÂ Internal Revenue Service, claiming it failed to protect...
Biora Therapeutics (NASDAQ:BIOR), formerly known as PROG stock was up more than +182% in the first week...